Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Zaja

Showing results (41-50 of 145) with videos related to

Pageof 15
Sort By:
Neurology(R) Neuroimmunology & Neuroinflammation|November 17, 2025
Immune Effector Cell-Associated Neurotoxicity Delayed Relapse After Chimeric Antigen Receptor T-Cell Therapy: A Case ReportAnna Favero, Sara Mohamed, Marta Lisa Battista, et al.
Annals of Hematology|April 23, 2016
Bendamustine plus rituximab versus R-CHOP as first-line treatment for patients with indolent non-Hodgkin's lymphoma: evidence from a multicenter, retrospective studyPatrizia Mondello, Normann Steiner, Wolfgang Willenbacher, et al.
Haematologica|May 15, 2003
B-cell compartment as the selective target for the treatment of immune thrombocytopeniasFrancesco Zaja, Nicola Vianelli, Alessandra Sperotto, et al.
Investigational New Drugs|February 1, 2021
A phase Ib, open-label, dose-escalation trial of the anti-CD37 monoclonal antibody, BI 836826, in combination with gemcitabine and oxaliplatin in patients with relapsed/refractory diffuse large B-cell lymphomaMonica Balzarotti, Massimo Magagnoli, Miguel Ángel Canales, et al.
American Journal of Hematology|November 28, 2023
Sustained response off-treatment in eltrombopag-treated adult patients with ITP who are refractory or relapsed after first-line steroids: Primary, final, and ad-hoc analyses of the Phase II TAPER trialNichola Cooper, Waleed Ghanima, Nicola Vianelli, et al.
Blood|July 30, 2009
The spectrum of Evans syndrome in adults: new insight into the disease based on the analysis of 68 casesMarc Michel, Valérie Chanet, Agnès Dechartres, et al.
Leukemia & Lymphoma|November 28, 2017
Treatment for patients with relapsed/refractory mantle cell lymphoma: European-based recommendationsMartin Dreyling, Igor Aurer, Sergio Cortelazzo, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 4, 2024
Preventive versus curative photobiomodulation for oral mucositis in patients with multiple myeloma undergoing hematopoietic stem cell transplantation: which approach is more effective?Katia Rupel, Arianna Cornacchia, Monica Poiani, et al.
European Journal of Haematology|June 16, 2010
Low-dose rituximab in adult patients with primary immune thrombocytopeniaFrancesco Zaja, Nicola Vianelli, Stefano Volpetti, et al.
Cancer|October 11, 2005
Gemcitabine as frontline treatment for cutaneous T-cell lymphoma: phase II study of 32 patientsEnrica Marchi, Lapo Alinari, Monica Tani, et al.
Pageof 15

Showing results (41-50 of 145) with videos related to

Sort By:
Pageof 15
Neurology(R) Neuroimmunology & Neuroinflammation|November 17, 2025
Immune Effector Cell-Associated Neurotoxicity Delayed Relapse After Chimeric Antigen Receptor T-Cell Therapy: A Case ReportAnna Favero, Sara Mohamed, Marta Lisa Battista, et al.
Annals of Hematology|April 23, 2016
Bendamustine plus rituximab versus R-CHOP as first-line treatment for patients with indolent non-Hodgkin's lymphoma: evidence from a multicenter, retrospective studyPatrizia Mondello, Normann Steiner, Wolfgang Willenbacher, et al.
Haematologica|May 15, 2003
B-cell compartment as the selective target for the treatment of immune thrombocytopeniasFrancesco Zaja, Nicola Vianelli, Alessandra Sperotto, et al.
Investigational New Drugs|February 1, 2021
A phase Ib, open-label, dose-escalation trial of the anti-CD37 monoclonal antibody, BI 836826, in combination with gemcitabine and oxaliplatin in patients with relapsed/refractory diffuse large B-cell lymphomaMonica Balzarotti, Massimo Magagnoli, Miguel Ángel Canales, et al.
American Journal of Hematology|November 28, 2023
Sustained response off-treatment in eltrombopag-treated adult patients with ITP who are refractory or relapsed after first-line steroids: Primary, final, and ad-hoc analyses of the Phase II TAPER trialNichola Cooper, Waleed Ghanima, Nicola Vianelli, et al.
Blood|July 30, 2009
The spectrum of Evans syndrome in adults: new insight into the disease based on the analysis of 68 casesMarc Michel, Valérie Chanet, Agnès Dechartres, et al.
Leukemia & Lymphoma|November 28, 2017
Treatment for patients with relapsed/refractory mantle cell lymphoma: European-based recommendationsMartin Dreyling, Igor Aurer, Sergio Cortelazzo, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 4, 2024
Preventive versus curative photobiomodulation for oral mucositis in patients with multiple myeloma undergoing hematopoietic stem cell transplantation: which approach is more effective?Katia Rupel, Arianna Cornacchia, Monica Poiani, et al.
European Journal of Haematology|June 16, 2010
Low-dose rituximab in adult patients with primary immune thrombocytopeniaFrancesco Zaja, Nicola Vianelli, Stefano Volpetti, et al.
Cancer|October 11, 2005
Gemcitabine as frontline treatment for cutaneous T-cell lymphoma: phase II study of 32 patientsEnrica Marchi, Lapo Alinari, Monica Tani, et al.
Pageof 15